SERTRALINE IN PARKINSON’S DISEASE
Objective: Depression is the most common psychiatric disorder in Parkinson’s disease (PD). Selective serotonin reuptake inhibitors (SSRIs) are currently used for treating depression in PD. Many cases of extrapyramidal side effects and exacerbation of PD symptoms due to SSRIs have been reported. The...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Mesut Çetin
2021-03-01
|
| Saila: | Psychiatry and Clinical Psychopharmacology |
| Gaiak: | |
| Sarrera elektronikoa: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/312 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|